How these proteins relate to the effect of LO remains to be uncovered, but a hint may lie in a previous report where genetic down-regulation of PAPPA by a protease inhibitor reduced ovarian cancer cell growth, invasion and metastatis via suppression of IGF-1-dependent Akt and ERK1/2 activation [86]. This evidence concerns the gene AKT1 and ovarian cancer.